A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.
Clinical trial NCT05444933 · COMPLETED
Trial details
- NCT number
- NCT05444933
- Sponsor
- Ipsen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-16
- Primary completion
- 2023-05-12
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.